Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have previously demonstrated that short-term coreceptor blockade with non-lytic monoclonal antibodies enables the long-term survival of fully allogeneic embryonic stem cell (ESC) transplants in mice. Here, we describe the use of Hu-PBL humanized mice to determine whether short-term coreceptor blockade with humanized anti-human CD4 and CD8 antibodies can achieve the same outcome towards human ESC derivatives. While control Hu-PBL mice rejected allogeneic hESC-derived transplants within weeks, mice treated with coreceptor blocking antibodies held their grafts for 7 weeks, the duration of the study. Rejection in the control mice was associated with demonstrable infiltrates of human CD45 white blood cells, predominantly of CD8 T-cells, whereas anti-CD4, but not anti-CD8 antibody treated mice showed remarkably reduced lymphocyte infiltration and prolonged allograft survival, indicating that the CD4+ T-cells were crucial to the rejection process. Our results give support to the principle that short-term blockade of T-cell co-receptors can achieve long-term acceptance of regenerative cell transplants in humans.

Original publication

DOI

10.1016/j.biomaterials.2020.120013

Type

Journal article

Journal

Biomaterials

Publication Date

07/2020

Volume

248

Keywords

Allograft, Humanized antibodies, Humanized mice, Immunogenicity, Pancreatic beta-like cells, Pluripotent stem cell therapy, Animals, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Graft Rejection, Graft Survival, Hematopoietic Stem Cell Transplantation, Humans, Mice, Mice, Inbred C57BL, Pluripotent Stem Cells, Transplantation, Homologous